Related Experiment Videos
Human IMR-32 neuroblastoma cells as a model cell line in Alzheimer's disease research
D Neill1, D Hughes, J A Edwardson
1School of Biology and Biochemistry, Queen's University of Belfast, Northern Ireland.
Abstract:
The present study investigated expression and processing of amyloid precursor protein by neuronally differentiated IMR-32 neuroblastoma cells. APP mRNA in these cells was found to consist of approximately 58% APP695, 38% APP751, and < 4% APP770. APP-immunoreactive bands detected in western blots of cellular protein extracts were only detected by anti-APP antibodies to peptides with strong homology to APLP2, suggesting that these bands represent APP-like proteins and not APP itself. This result suggests that previous studies claiming immunodetection of cellular forms of APP may have to be re-evaluated. Four main species of C-terminal truncated, secreted APP were detected in blots of protein extracts from medium conditioned by these cells. The immunoreactive profile of these bands suggested a cleavage site N-terminal to the Lys16-Leu17 bond of alpha-secretase. This, together with differences in number and molecular mass of APP-immunoreactive bands between secreted APP from IMR-32 cells and that from the commonly used PC-12 cells, suggests differences in APP processing between these two neuronally differentiated cell lines. In theory, IMR-32 cells being of human neuronal origin may be a more appropriate cell line to study APP-processing in relation to Alzheimer's disease than the rat phaeochromocytoma PC-12 cell line. Therefore, these detected differences warrant further investigation. Additionally IMR-32 cells under certain tissue culture conditions can form intracellular fibrillary material that reacts with anti-PHF specific antibodies. Neuronally differentiated IMR-32 cells could therefore be used as a model system to investigate possible interactions between APP-processing and PHF formation.
Insights
This study reveals neuronally differentiated IMR-32 cells process amyloid precursor protein (APP) differently than PC-12 cells. These human cells may offer a better model for Alzheimer's disease research and studying APP-processing interactions with PHF formation.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Amyloid precursor protein (APP) processing is central to Alzheimer's disease pathogenesis.
- Understanding APP expression and processing in neuronal models is crucial for disease research.
- IMR-32 neuroblastoma cells offer a human neuronal model for studying APP.
Purpose of the Study:
- To investigate APP expression and processing in neuronally differentiated IMR-32 cells.
- To compare APP processing in IMR-32 cells with the commonly used PC-12 cell line.
- To evaluate IMR-32 cells as a model for studying APP interactions with PHF formation.
Main Methods:
- Western blotting of cellular protein extracts and conditioned medium.
- Immunodetection using anti-APP antibodies and antibodies specific to APLP2 and PHF.
- Analysis of APP mRNA splicing variants (APP695, APP751, APP770).
Main Results:
- IMR-32 cells express APP mRNA variants, predominantly APP695.
- APP-immunoreactive bands in cell extracts likely represent APP-like proteins (APLP2), not APP itself.
- Four species of C-terminal truncated, secreted APP were detected, suggesting alpha-secretase cleavage.
- Differences in secreted APP profiles were observed between IMR-32 and PC-12 cells.
- Neuronally differentiated IMR-32 cells formed intracellular fibrillary material reactive with anti-PHF antibodies.
Conclusions:
- Previous studies on cellular APP detection may require re-evaluation due to potential APLP2 cross-reactivity.
- IMR-32 cells exhibit distinct APP processing compared to PC-12 cells, suggesting they may be a more relevant model for Alzheimer's disease.
- IMR-32 cells can serve as a valuable model system to explore the interplay between APP processing and PHF formation.